Pharmaceuticals

CARsgen Announces the Publication of a Novel CAR-T Technology that Improves the Efficacy of CAR-T cells Against Solid Tumors without Requiring Preconditioned Lymphodepletion

SHANGHAI, Aug. 17, 2020 /PRNewswire/ -- CARsgen Therapeutics, a leader in developing novel CAR-T cell therapies against solid tumors, today announced its publication of the 7×21 CAR-T technology in CLINICAL CANCER RESEARCH. The article is titled "Coexpression of IL-7 and CCL21 increases efficacy ...

2020-08-17 18:00 4041

First HBV Patient Dosed in Phase IIa Clinical Trial of ASC22, a Subcutaneously Administered PD-L1 Antibody

HANGZHOU, China and SHAOXING, China, Aug. 17, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today dosing of the first HBV patient in Phase IIa clinical trial of ASC22, which is a first-in-class, subcutaneously administered PD-L1 antibody. ASC22(Envafolimab) Phase IIa clin...

2020-08-17 08:30 3955

Sai Life Sciences opens new, state-of-the-art Research & Technology Centre in Hyderabad

HYDERABAD, India, Aug. 17, 2020 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growing Contract Development & Manufacturing Organizations (CDMOs) , today announced the inauguration of its new Rese...

2020-08-17 08:00 3826

China's First Trastuzumab Biosimilar Approved by NMPA

SHANGHAI, Aug. 17, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced onAugust 14 that the trastuzumab biosimilar HLX02, developed and manufactured by Henlius independently, has been approved by the National Medical Products Administration (NMPA). On 27th July, HLX02 (EU bran...

2020-08-17 08:00 4385

Ascentage Pharma Becomes a Constituent of Three Major Indexes Including Hang Seng Composite Index

SUZHOU, China, and ROCKVILLE, MD., Aug. 17, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company has been s...

2020-08-17 07:30 3152

Memo Therapeutics AG and Northway Biotechpharma Collaborate on the Fast-Track Manufacturing of a SARS-CoV-2-Neutralizing Antibody for the Therapy of COVID-19

SCHLIEREN, Switzerland and VILNIUS, Lithuania, Aug. 15, 2020 /PRNewswire/ -- Swiss biotech companyMemo Therapeutics AG (MTx) and Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announce a new partnership to manufacture MTx...

2020-08-15 08:36 4657

Bushu Pharmaceuticals Announces Major Expansion Program

KAWAGOE, Japan, Aug. 14, 2020 /PRNewswire/ -- - Japan's Premier CDMO Will Invest $100m to Expand Capacity and Portfolio - Bushu Pharmaceuticals Ltd., one of Japan's largest contract manufacturers of pharmaceutical products, announced onAugust 14 a major capital program costing $100 million to ex...

2020-08-14 14:00 2579

Sinopharm Tech plans to purchase 337 tons Meltblown Fabric

HONG KONG, August 14, 2020 /PRNewswire/ -- Sinopharm Tech Holdings Limited ("Sinopharm Tech" and its subsidiaries, together, the "Group", stock code: 8156)  is pleased to announce that, as of 13 August, 2020, the subsidiary of the Group has entered into product sales agreements with a branch of Pe...

2020-08-14 09:18 4906

Zai Lab Announces Financial Results for Six Months Ended June 30, 2020 and Corporate Updates

SHANGHAI and SAN FRANCISCO, Aug. 13, 2020 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB), an innovative commercial-stage biopharmaceutical company, today announced financial results for the six months ended June 30, 2020 and corporate updates. "This year we have continued to build Zai Lab's lead...

2020-08-13 22:38 6978

AGC Biologics Enters into Partnership as a CDMO with Ono Pharmaceuticals to Manufacture Biopharmaceuticals at Clinical Development Stage

SEATTLE, Aug. 13, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it is partnering with Ono Pharmaceutical Co., Ltd. (ONO) to manufacture new, innovative biopharmaceuticals at the clinical development stage. ONO...

2020-08-13 21:00 4981

ANTI-PD-1/CTLA-4 Bi-specific Antibody (AK104) of Akeso Granted FDA Fast Track Designation for Recurrent and Metastatic Cervical Cancer

LOS ANGELES, Aug. 13, 2020 /PRNewswire/ -- Akeso, Inc (9926.HK) - a biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of new innovative antibody drugs that are affordable to patients worldwide - today announced that the U.S. Food and Drug Admini...

2020-08-13 20:07 5497

Ajinomoto Bio-Pharma Services Expands Small Molecule Manufacturing Capabilities at its India Facility

WETTEREN, Belgium, Aug. 13, 2020 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce a major expansion of small molecule manufacturing capabilities with the addition of a ...

2020-08-13 20:06 3335

CanSinoBIO's Successful Listing on STAR Market Makes it the Initial Dual Listing Vaccine Company

SHANGHAI, Aug. 13, 2020 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SHSE: 688185, HKEX:06185) announced today that it has successfully listed on the Sci-Tech Innovation Board (STAR Market) of the Shanghai Stock Exchange, making it the first "A+ H" dual listing vaccine company. CanSinoB...

2020-08-13 10:00 10877

Australian Therapeutic Goods Administration Approves the First Phase I Trial of ATG-017 for the Treatment of Patients with Advanced Solid Tumors and Hematological Malignancies

SHANGHAI and MELBOURNE, Australia, Aug. 13, 2020 /PRNewswire/ -- Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company, announced today the authorization of the first-in-human trial of ATG-017 (ERASER trial) by the Australian Therapeutic Goods Admi...

2020-08-13 06:00 2580

Health Canada provides COVID-19 Interim Order approval for Bactiguard's endotracheal tubes

STOCKHOLM, Aug. 13, 2020 /PRNewswire/ -- Health Canada has approved Bactiguard's endotracheal tubes for infection prevention through an Interim Order. The approval is driven by COVID-19, as Bactiguard's endotracheal tubes can reduce the risk of secondary infections for critically ill patients. "...

2020-08-13 04:33 3021

PharmaSources Launches the Export-Driven Event CPhI & P-MEC China E-Trade Season

SHANGHAI, Aug. 11, 2020 /PRNewswire/ -- PharmaSources, an international B2B trade portal for the pharmaceutical verticals, is launching the virtual event CPhI & P-MEC China E-Trade Season from August toDecember 2020. Consisting of the three sessions "Top API Exporters & Products", "Popular Natura...

2020-08-11 18:35 3568

TCM Lianhua Qingwen Capsule approved for registration in the Philippines

SHIJIAZHUANG, China, Aug. 11, 2020 /PRNewswire/ -- Yiling Pharmaceutical Co., Ltd.announced on Monday that it has received a drug registration certificate issued by the Food and Drug Administration ofthe Philippines, indicating Lianhua Qingwen Capsule has been registered in accordance with the st...

2020-08-11 17:31 4243

AGC Biologics Expands Partnership with Novavax

Manufacturing of Novavax' Matrix-M™Adjuvant for Novel COVID-19 Vaccine Expands toSeattle SEATTLE, Aug. 11, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it has expanded its partnership withNovavax, Inc. (NASDA...

2020-08-11 04:20 6872

New Thermo Scientific Selectris Filters Push Cryo-EM Boundaries with Atomic Resolution

Zero-loss energy filters enable life scientists to view protein structures in unprecedented detail HILLSBORO, Oregon, Aug. 11, 2020 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today introduced two breakthrough imaging filters, the Thermo Scientific Selectris Im...

2020-08-11 04:17 3834

PHC Holdings Corporation and Ascensia Diabetes Care Announce Financing Agreement and Exclusive Global Commercial Agreement With Senseonics

TOKYO and BASEL, Switzerland, Aug. 11, 2020 /PRNewswire/ -- PHC Holdings Corporation and Ascensia Diabetes Care, a PHC Group company, today announced a strategic partnership with Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of long-term,...

2020-08-11 04:02 3610
1 ... 284285286287288289290 ... 313

Week's Top Stories